| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.43 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.3 | 9e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.29 | 9e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.29 | 2e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.27 | 2e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.24 | 0.0001 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.23 | 0.5 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.23 | 4e-09 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.22 | 0.001 |